Spisulosine

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameSpisulosine
Drug Alias NameSpisulosine 285ES-285
ClassificationNatural product/ExtractSmall molecules
Mechanisms of ActionCaspase-3 activatorsSphingosine kinase 1 activators
TargetsSphingosine kinase 1Caspase-3
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPharma Mar Sa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPharma Mar Sa
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A